$MRSH

Jones John Jude sold $1.2M of MRSH

Jones John Jude (Chief Marketing Officer) sold 6,500 shares of MARSH & MCLENNAN COMPANIES, INC. (MRSH) at $191.96 ($1.25M total) on 2026-08-06.

Original reporting
SEC EDGAR · Jones John Jude
Published Aug 7, 2026, 8:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 7, 2026, 8:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$MRSH
Neutral
high confidence
Mentioned
$MRSH
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MRSHNeutralLow
01

Why it matters

The only new information is the reported sale size, price, and post-transaction holdings by the CMO. There is no accompanying corporate action or guidance change.

02

Market read

Traders may monitor insider activity for sentiment, but this specific disclosure lacks fundamental catalysts in the provided text.

03

What to watch

The article does not state whether the sale was part of a 10b5-1 plan (it says no), but it also provides no context on compensation, tax obligations, or prior holdings beyond the post-transaction share count.

Relevance 6/10Novelty 3/10Timing: filed Aug 7, 2026 after-hours (20:03:42 UTC)

Background

The article is an SEC Form 4 insider transaction disclosure for Marsh & McLennan (MRSH).

Company-level read

Ticker impact

$MRSHNeutralHigh confidence
Context

Marsh & McLennan CMO Jones John Jude sold 6,500 shares in an open-market transaction worth about $1.25M, per a fresh Form 4 filing.

Expected impact

Low near-term impact; any reaction is likely limited unless accompanied by unusual volume or additional disclosures.

Evidence & confidence

The filing is a routine insider transaction (open-market sale) with no 10b5-1 plan and no accompanying guidance, contract, or regulatory event in the text.

Market effects

No clear sector read-through from a single routine insider sale.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification, taxes, or pre-planned liquidity needs, so the signal may be overstated.

Key entities

  • Marsh & McLennan Companies, Inc.

    Subject of the Form 4 insider sale disclosure (MRSH).

  • Jones John Jude

    Chief Marketing Officer who sold 6,500 shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MRSHMedAI 8/10

Why Marsh (MRSH) Stock Is Trading Up Today

Marsh (MRSH) shares rose 4.7% after reporting Q3 2026 results with 8% revenue growth and 10% increase in adjusted EPS. GAAP earnings were $1.69, adjusted earnings $2.03. The company repurchased $500M in stock and raised its savings target to $600M. Shares closed at $186.43, up 4.5%.

$MRSHHighAI 8/10

Marsh McLennan earnings analysis: questions answered and next catalysts

Marsh McLennan (MRSH) reported Q3 FY2026 earnings on Oct 15, 2026, beating estimates with EPS of $2.03 and revenue of $6.86B. The stock rose 5.49% to $188.19. Analysts had lowered price targets before the report, contributing to the rally. Key questions remain about organic growth durability and valuation. Next catalysts include Q4 earnings, 2027 guidance, and analyst revisions.

$MRSHHighAI 8/10

Marsh McLennan (MRSH) Q3 2026 Earnings Call Transcript

Marsh McLennan (MRSH) reported Q3 2026 earnings with revenue up 8%, adjusted operating income up 6%, and adjusted EPS up 10%. The company highlighted growth in consulting and risk services, increased Thrive savings target to $600M, and progress in AI integration. They also repurchased $500M in stock. Market conditions showed mixed rate changes across regions and lines of business.